Pacific Biosciences (PACB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2020 | 12-2019 | 09-2019 | 06-2019 | 03-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 68,862 | 29,927 | 33,084 | 30,358 | 38,205 |
| Marketable Securities | 73,729 | 19,472 | 16,120 | 36,486 | 44,667 |
| Receivables | 7,325 | 15,266 | 9,966 | 12,123 | 7,279 |
| Inventories | 16,124 | 13,312 | 15,067 | 17,404 | 19,650 |
| TOTAL | $169,530 | $81,046 | $76,941 | $98,909 | $112,588 |
| Non-Current Assets | |||||
| PPE Net | 29,076 | 30,070 | 31,618 | 33,457 | 33,613 |
| Other Non-Current Assets | 36,158 | 36,869 | 37,551 | 38,216 | 39,376 |
| TOTAL | $65,234 | $66,939 | $69,169 | $71,673 | $72,989 |
| Total Assets | $234,764 | $147,985 | $146,110 | $170,582 | $185,577 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,223 | 8,368 | 8,111 | 8,011 | 8,740 |
| Accrued Expenses | 17,963 | 13,242 | 15,823 | 14,107 | 11,158 |
| Other current liabilities | 714 | 225 | 1,110 | 1,764 | 312 |
| TOTAL | $131,974 | $49,153 | $50,693 | $49,453 | $45,097 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 105,107 | 7,610 | 6,379 | 6,707 | 6,428 |
| Other Non-Current Liabilities | 40,903 | 41,964 | 42,968 | 43,921 | 44,861 |
| TOTAL | $42,387 | $43,915 | $44,403 | $45,375 | $45,630 |
| Total Liabilities | $174,361 | $93,068 | $95,096 | $94,828 | $90,727 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 154,068 | 153,136 | 153,034 | 152,965 | 152,675 |
| Common Shares | 154 | 153 | 153 | 153 | 153 |
| Retained earnings | -1,065,010 | -1,066,240 | -1,066,149 | -1,037,026 | -1,012,430 |
| Other shareholders' equity | 30 | 5 | 11 | 17 | 6 |
| TOTAL | $60,403 | $54,917 | $51,014 | $75,754 | $94,850 |
| Total Liabilities And Equity | $234,764 | $147,985 | $146,110 | $170,582 | $185,577 |